Horizon Financial Services’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.3K Buy
71
+3
+4% +$1.06K 0.01% 220
2026
Q2
$24.4K Hold
68
– – 0.01% 239
2026
Q1
$17K Buy
68
+35
+106% +$8.71K 0.01% 209
2025
Q4
$9.08K Hold
33
– – ﹤0.01% 201
2025
Q3
$8.66K Buy
33
+26
+371% +$6.32K ﹤0.01% 199
2025
Q2
$1.53K Buy
7
+3
+75% +$641 ﹤0.01% 247
2025
Q1
$896 Buy
+4
New +$1.1K ﹤0.01% 230

Other funds holding WST

Horizon Financial Services's WST Position: Q3 2026 in Review

Horizon Financial Services increased its West Pharmaceutical (WST) stake by 4.4% in Q3 2026, buying an estimated $1.06K and bringing the position to 71 shares worth $26.3K. The position accounts for 0.01% of the portfolio, ranked #220.

Horizon Financial Services first reported a position in WST in Q1 2025 and has held it in 7 quarters since. 877 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Horizon Financial Services held 71 shares of West Pharmaceutical worth $26.3K as of Q3 2026.
  • Horizon Financial Services bought 3 West Pharmaceutical shares in Q3 2026, an estimated $1.06K.
  • West Pharmaceutical made up 0.01% of Horizon Financial Services's portfolio in Q3 2026, its #220 holding.
  • Horizon Financial Services first reported a position in West Pharmaceutical in Q1 2025 and has held it in 7 quarters since.
  • 877 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Horizon Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.